EMRX101 – Healthtost

ExiVex reports human pharmacokinetic data showing that intranasal naloxone EMRX-101 approaches peak plasma concentrations similar to IV with a significantly faster Tmax than the currently approved comparator

By healthtostMay 15, 20260

ExiVex Biopharma (formerly EmerRx Biopharma), a clinical-stage pharmaceutical company developing a proprietary dual-chamber intranasal drug delivery platform, today announced human…

What's Hot

Browsing: EMRX101